Products

Insider Intelligence delivers leading-edge research to clients in a variety of forms, including full-length reports and data visualizations to equip you with actionable takeaways for better business decisions.
Reports
In-depth analysis, benchmarks and shorter spotlights on digital trends.
Learn More
Forecasts
Interactive projections with 10k+ metrics on market trends, & consumer behavior.
Learn More
Charts
Proprietary data and over 3,000 third-party sources about the most important topics.
Learn More
Industry KPIs
Industry benchmarks for the most important KPIs in digital marketing, advertising, retail and ecommerce.
Learn More
Briefings
Client-only email newsletters with analysis and takeaways from the daily news.
Learn More
Analyst Access Program
Exclusive time with the thought leaders who craft our research.
Learn More

About Insider Intelligence

Our goal at Insider Intelligence is to unlock digital opportunities for our clients with the world’s most trusted forecasts, analysis, and benchmarks. Spanning five core coverage areas and dozens of industries, our research on digital transformation is exhaustive.
Our Story
Learn more about our mission and how Insider Intelligence came to be.
Learn More
Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Contact Us
Speak to a member of our team to learn more about Insider Intelligence.
Contact Us
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Advertising & Sponsorship Opportunities
Reach an engaged audience of decision-makers.
Learn More
Events
Browse our upcoming and past events, recent podcasts, and other featured resources.
Learn More
Podcasts
Tune in to eMarketer's daily, weekly, and monthly podcasts.
Learn More

Walgreens’ healthcare division shines in Q2 earnings

The news: Walgreens Boots Alliance posted higher sales but lower profits in Q2 2023 as COVID-19 vaccinations plummeted, and the company digested its $3.5 billion debt and equity investment in VillageMD’s acquisition of Summit Health in January.

  • Sales increased 3.3% year over year (YoY) to $34.9 billion, while net earnings slid 19.8% to $703 million.
  • Just 2.4 million vaccinations were administered in Q2 compared with 11.8 million the prior year’s Q2.
  • The US healthcare division had sales of $1.6 billion, up $1.1 billion from Q2 2022, but posted an operating loss of $472 million.

The pivot to healthcare from retail continues: Walgreens calls consumer-centric health solutions its next growth engine. Other Q2 highlights for its healthcare division include:

  • Its $1.37 billion acquisition of specialty pharmacy Shields Health Solutions.
  • The retailer now manages 806,000 valued-based lives under VillageMD/Summit.
  • It operates 210 VillageMD clinics that are next door to Walgreens pharmacies.
  • VillageMD ended the quarter with 729 locations, including Summit Health and CityMD.
  • Nearly 50% of patients in those co-located clinics opted to fill their prescriptions next door at the Walgreens pharmacy, CFO James Kehoe said on the earnings call.
  • Walgreens Health Corners, which provide in-store and virtual health services, grew 47% YoY, to 117 locations.
  • It now has five clinical trials contracts since it entered the field in June 2022.

Looking ahead: Walgreens won’t slow down building out its primary care and home health offerings.

  • Its $392 million deal for the remaining 45% of CareCentrix is expected to close in fiscal Q3.
  • Walgreens and VillageMD launched a pilot program to help patients manage their medications after discharge from the hospital.

Our take: Walgreens is giving its rivals CVS Health and Walmart a run for their money. The Summit Health deal greatly expanded its market presence and its offerings, adding multispecialty and urgent care clinics to VillageMD’s primary care clinics.

  • Walgreens will see 20.8 million patients in its retail clinics in 2023, we estimate.
  • That’s about one-quarter (24.8%) of all US retail clinic patients.
  • In 2024, it will see 21.9 million patients, up 5.7% from 2023.

This article originally appeared in Insider Intelligence's Digital Health Briefing—a daily recap of top stories reshaping the healthcare industry. Subscribe to have more hard-hitting takeaways delivered to your inbox daily.